Test Price
2,800 AED✅ Home Collection Available
STIM1 Gene (Stormorken Syndrome) Genetic Test
Executive Summary & Core Metrics
Executive Summary: This genetic test utilizes next-generation sequencing (NGS) to comprehensively analyze the STIM1 gene, confirming or excluding a diagnosis of Stormorken syndrome with 99.9% diagnostic sensitivity through ISO‑accredited processing. Premium logistics include VIP mobile phlebotomy and temperature‑controlled cold‑chain home collection (available daily 8 AM–11 PM). Complimentary telephonic post‑test clinical guidance is provided. Direct billing verification via WhatsApp at +971 54 548 8731.
Test Overview & Methodology
Next‑generation sequencing (NGS) of the entire coding region and splice sites of the STIM1 gene is performed. The assay identifies pathogenic variants associated with Stormorken syndrome—an autosomal dominant disorder characterised by thrombocytopenia, myopathy, asplenia, miosis, and ichthyosis. Results must be interpreted in the context of clinical findings and family history.
| Feature | Our Test (NGS) | Closest Alternative (Sanger) |
|---|---|---|
| Precision | 99.9% diagnostic sensitivity for point mutations & small indels | Limited to targeted amplicons; may miss deep intronic variants |
| Methodology | NGS – full gene sequencing | Sanger – single region, single exon |
| Turnaround Time | 3–4 Weeks | 4–6 Weeks (if multiple exons required) |
Physician Insight & Safety Protocols
“The STIM1 NGS test is a definitive tool for identifying pathogenic variants linked to Stormorken syndrome. Results must be correlated with clinical findings and family history. Our team provides compassionate, clear guidance throughout every patient’s diagnostic journey.”
— Lina Osama Zaki Quteineh | Consultant Medical Genetics | DHA Registration ID: 9294403
Medication Advisory
Do not discontinue any prescribed medication without direct consultation with your treating physician. This test provides genetic information, not a change in acute therapy. Manage all medications under the supervision of your healthcare provider.
Exclusion Criteria & ER Red Flags
- Minors (under 18 years) must be accompanied by a legal guardian with valid consent; testing without consent violates Federal Decree-Law No. 4 of 2016 on Medical Liability.
- Acute febrile illness or active infection may delay sample collection.
- Known severe allergy to skin antiseptics (e.g., chlorhexidine) must be disclosed prior to phlebotomy.
- Seek emergency care immediately if: sudden severe bleeding, confusion, stiff neck, or high fever—these may indicate complications related to asplenia or platelet dysfunction.
Patient FAQ & Clinical Guidance
1. What does the STIM1 genetic test reveal?
It identifies pathogenic variants in the STIM1 gene to confirm Stormorken syndrome, guiding platelet and muscle management. A positive result supports targeted surveillance for bleeding risks and associated complications such as asplenia.
2. How is the sample collected, and is home service available?
A simple blood draw is performed. DHA‑licensed phlebotomists provide VIP mobile home collection from 8 AM to 11 PM using temperature‑controlled cold‑chain logistics. Alternatively, you may visit any DNA Labs UAE collection centre.
3. Will insurance cover this test?
Many UAE insurers cover genetic testing when clinically indicated for suspected Stormorken syndrome. Verify your coverage directly via WhatsApp at +971 54 548 8731 for pre‑authorisation and direct billing assistance.
UAE Regulatory & Data Privacy Adherence
Regulatory Compliance: All procedures comply with Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Patient consent and clinical safety follow Federal Decree‑Law No. 4 of 2016 on Medical Liability. This laboratory is DHA‑licensed and ISO 9001:2015 certified.
Clinical & Logistical Metadata
| Test Name | STIM1 Gene (Stormorken Syndrome) Genetic Test |
| Price (AED) | 2,800 |
| Turnaround Time | 3–4 Weeks |
| Sample Type / Matrix | Peripheral whole blood (EDTA) – VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection |
| Methodology Used | Next‑Generation Sequencing (NGS) – full gene sequencing |
| ICD‑10‑CM Code | D69.1 |
| LOINC Code | 61693-7 |
| DHA Facility License & Laboratory Address | DHA License: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE – DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians